Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.5.0.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
CURRENT ASSETS    
Cash and cash equivalents $ 10,716 $ 19,459
Accounts receivable, net of allowance for doubtful accounts 13,679 6,621
Other current assets 2,185 2,118
Total current assets 26,580 28,198
FIXED ASSETS, net of accumulated depreciation 4,912 6,069
OTHER ASSETS    
Restricted cash 300 300
Patents and other intangible assets, net of accumulated amortization 1,594 1,727
Investment in joint venture 296 341
Goodwill 12,029 12,029
Other 112 220
Total other assets 14,331 14,617
Total Assets 45,823 48,884
CURRENT LIABILITIES    
Accounts payable and accrued expenses 8,341 7,579
Obligations under capital leases, current portion 69 122
Deferred revenue 210 831
Bank term note, current portion 2,000 1,333
Total current liabilities 10,620 9,865
Obligations under capital leases 228 276
Deferred rent payable and other 299 315
Warrant liability 2,814 17
Deferred revenue, long-term 864 752
Bank term note 3,151 4,642
Total Liabilities 17,976 15,867
STOCKHOLDERS’ EQUITY    
Preferred stock, authorized 9,764 shares, $0.0001 par value, none issued 0 0
Common stock, authorized 100,000 shares, $0.0001 par value, 18,870 and 13,652 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively 2 1
Additional paid-in capital 139,023 131,167
Accumulated (deficit) (111,178) (98,151)
Total Stockholders’ Equity 27,847 33,017
Total Liabilities and Stockholders’ Equity $ 45,823 $ 48,884